Dr. Lev Verkh
Details
Dr. Lev Verkh
Dr. Verkh has directed national and multi-national Phase I, II, III and IV clinical trials in such areas as cardiology, oncology, neurology, peripheral vascular diseases, hematology, blood disorders and imaging methods. Through his efforts and the efforts of his teams, he has received FDA approval for several products that are currently on the market. Under his leadership, Stemedica obtained several INDs for clinical trials in the United States and emergency INDs from the FDA.
Previous
Previous
Next
Copyright: Jiuzhitang Maker (Beijing) Cell Technology Co., Ltd.
Business License
